Lv51
1070 积分 2022-05-20 加入
Disrupted molecular glue complex drives RAS inhibitor resistance
10小时前
待确认
First PROTAC gains FDA approval, bolstering targeted protein degradation and induced proximity ambitions
10小时前
已完结
Clinical pharmacokinetics and pharmacodynamics of ivosidenib in patients with advanced hematologic malignancies with an IDH1 mutation
3个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
7个月前
已完结
皖公网安备34019202002308
